NCT05571813View on ClinicalTrials.gov

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

December 4, 2022

Study Completion Date

December 23, 2022

Conditions
Hypertension
Interventions
DRUG

CKD-341

A single dose of 1tablets under fasting condition

Trial Locations (1)

Unknown

Central Hospital, Gyeonggi-do

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT05571813 - Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects | Biotech Hunter | Biotech Hunter